citric acid, anhydrous has been researched along with Adenoma, Prostatic in 15 studies
Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The (choline + creatine)/ citrate values in regions of histologically confirmed benign prostatic hyperplasia (0." | 3.69 | Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. ( Carroll, PR; Hricak, H; Kurhanewicz, J; Nelson, SJ; Parivar, F; Shinohara, K; Vigneron, DB, 1996) |
| " Differences in lactate dehydrogenase (LDH) isoenzymes, complement C3, and transferrin concentrations in the prostatic fluid of men with histologically identified carcinoma (Ca) and benign prostatic hyperplasia (BPH) have been observed." | 3.66 | Biochemical profiles of prostatic fluid from normal and diseased prostate glands. ( Grayhack, JT; Lee, C; Oliver, L; Schaeffer, AJ; Wendel, EF, 1980) |
| "1H spectra from prostate cancer patients were correlated with pathologic areas identified on T2-weighted endorectal coil magnetic resonance (MR) images and histologic study of the step-sectioned gland after surgery." | 2.68 | Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. ( Hricak, H; Konety, B; Kurhanewicz, J; MacDonald, JM; Narayan, P; Nelson, SJ; Vigneron, DB, 1995) |
| "An estimate of the spatial extent of prostate cancer was determined by generating metabolite images in which this metabolite ratio significantly exceeded normal peripheral zone values in multiple contiguous sections." | 1.29 | Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. ( Carroll, P; Hricak, H; Kurhanewicz, J; Narayan, P; Nelson, SJ; Vigneron, DB, 1996) |
| "Cell strains derived from prostate cancers tended to have smaller amounts of citrate than those from normal prostate epithelium." | 1.28 | In vitro proton spectroscopy of normal and abnormal prostate. ( Peehl, D; Sommer, G; Yacoe, ME, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (33.33) | 18.7374 |
| 1990's | 7 (46.67) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, D | 1 |
| Gupta, A | 1 |
| Mandhani, A | 1 |
| Sankhwar, SN | 1 |
| Yue, K | 1 |
| Marumoto, A | 1 |
| Binesh, N | 1 |
| Thomas, MA | 1 |
| COOPER, JF | 1 |
| IMFELD, H | 1 |
| Kumar, R | 1 |
| Kumar, M | 1 |
| Jagannathan, NR | 1 |
| Gupta, NP | 1 |
| Hemal, AK | 1 |
| Grayhack, JT | 1 |
| Lee, C | 1 |
| Oliver, L | 1 |
| Schaeffer, AJ | 1 |
| Wendel, EF | 1 |
| Costello, LC | 1 |
| Franklin, RB | 1 |
| Kurhanewicz, J | 3 |
| Vigneron, DB | 3 |
| Nelson, SJ | 3 |
| Hricak, H | 3 |
| MacDonald, JM | 1 |
| Konety, B | 1 |
| Narayan, P | 2 |
| Carroll, P | 1 |
| Parivar, F | 1 |
| Shinohara, K | 1 |
| Carroll, PR | 1 |
| Liney, GP | 1 |
| Turnbull, LW | 1 |
| Lowry, M | 1 |
| Turnbull, LS | 1 |
| Knowles, AJ | 1 |
| Horsman, A | 1 |
| García-Segura, JM | 1 |
| Sánchez-Chapado, M | 1 |
| Ibarburen, C | 1 |
| Viaño, J | 1 |
| Angulo, JC | 1 |
| González, J | 1 |
| Rodríguez-Vallejo, JM | 1 |
| Yacoe, ME | 1 |
| Sommer, G | 1 |
| Peehl, D | 1 |
| Fadika, GO | 1 |
| Gambhir, KK | 1 |
| Neurarker, SG | 1 |
| Jackson, AG | 1 |
| Leffall, LD | 1 |
| Jones, GW | 1 |
| Davis, JL | 1 |
| Gregory, H | 1 |
| Willshire, IR | 1 |
| Kavanagh, JP | 1 |
| Blacklock, NJ | 1 |
| Chowdury, S | 1 |
| Richards, RC | 1 |
| Le Goff, JM | 1 |
| Martin, PM | 1 |
| Ojasoo, T | 1 |
| Raynaud, JP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Trans-Rectal Placement of Prostatic Fiducial Markers Under MR-Guidance in Patients Receiving External Beam Radiotherapy for Prostate Cancer: A Pilot Study[NCT00061347] | Phase 1 | 15 participants (Actual) | Interventional | 2003-05-23 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for citric acid, anhydrous and Adenoma, Prostatic
| Article | Year |
|---|---|
Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy.
Topics: Adenocarcinoma; Aged; Biomarkers; Case-Control Studies; Citrates; Citric Acid; Diagnosis, Differenti | 1995 |
14 other studies available for citric acid, anhydrous and Adenoma, Prostatic
| Article | Year |
|---|---|
NMR spectroscopy of filtered serum of prostate cancer: A new frontier in metabolomics.
Topics: Aged; Biomarkers, Tumor; Biopsy; Citric Acid; Diagnosis, Differential; Digital Rectal Examination; G | 2016 |
2D JPRESS of human prostates using an endorectal receiver coil.
Topics: Adult; Biomarkers, Tumor; Choline; Citric Acid; Creatine; Humans; Magnetic Resonance Spectroscopy; M | 2002 |
The role of citric acid in the physiology of the prostate: a preliminary report.
Topics: Citrates; Citric Acid; Humans; Hypertrophy; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplas | 1958 |
Proton magnetic resonance spectroscopy with a body coil in the diagnosis of carcinoma prostate.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Choline; Citric Acid; Creatine; Diagnosis, Differential; | 2004 |
Biochemical profiles of prostatic fluid from normal and diseased prostate glands.
Topics: Acid Phosphatase; Adult; Cholesterol; Citric Acid; Complement C3; Complement C4; Ferritins; Humans; | 1980 |
Bioenergetic theory of prostate malignancy.
Topics: Aconitate Hydratase; Adenosine Triphosphate; Citrates; Citric Acid; Energy Metabolism; Humans; Male; | 1994 |
Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
Topics: Adenocarcinoma; Adult; Aged; Choline; Citrates; Citric Acid; Creatine; Diagnosis, Differential; Huma | 1996 |
Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging.
Topics: Aged; Choline; Citrates; Citric Acid; Creatine; Cryosurgery; Humans; Magnetic Resonance Imaging; Mag | 1996 |
In vivo quantification of citrate concentration and water T2 relaxation time of the pathologic prostate gland using 1H MRS and MRI.
Topics: Adenocarcinoma; Aged; Biopsy; Body Water; Citric Acid; Diagnosis, Differential; Humans; Magnetic Res | 1997 |
In vivo proton magnetic resonance spectroscopy of diseased prostate: spectroscopic features of malignant versus benign pathology.
Topics: Aged; Aged, 80 and over; Choline; Citric Acid; Creatine; Diagnosis, Differential; Humans; Inositol; | 1999 |
In vitro proton spectroscopy of normal and abnormal prostate.
Topics: Adenocarcinoma; Carbon; Cells, Cultured; Citrates; Citric Acid; Gas Chromatography-Mass Spectrometry | 1991 |
The effect of citrate and polyamines on human benign prostate in organ culture.
Topics: Citrates; Citric Acid; Culture Media; Humans; Male; Polyamines; Prostate; Prostatic Hyperplasia; Tes | 1985 |
Urogastrone-epidermal growth factor concentrations in prostatic fluid of normal individuals and patients with benign prostatic hypertrophy.
Topics: Chromatography, Gel; Citrates; Citric Acid; Epidermal Growth Factor; Humans; Male; Phosphates; Prost | 1986 |
Non-michaelian behavior of 5 alpha-reductase in human prostate.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Citrates; Citric Acid; Humans; In Vitro Techniques; Kinetics; | 1989 |